Bristol Myers Squibb (BMY)

Operating Cash Flow Growth

-19.62%

TTM · Period ending:

BMY logo

BMY Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-19.62%
BMY TTM Cash from Operations YoY % (4.74% → -19.62%)
High-resolution chart · PNG

BMY operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bristol Myers Squibb Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
23.931%
12.5789%
8.3877%
8.0884%
0.046%
7.9778%
4.1748%
25.9021%
56.6282%
48.4076%
66.3974%
28.6895%
12.9373%
-1.6218%
-6.2476%
-3.2%
-7.2453%
14.9089%
5.6823%
4.4984%
18.8874%
0.1272%
8.605%
4.2324%
-18.4413%
-17.6388%
-10.814%
-2.0325%
16.745%
40.1371%
27.2189%
20.3523%
25.9279%
9.7797%
10.5177%
19.1142%
12.3942%
6.8926%
4.7374%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.